Lung Cancer Screening 2025

Breathe Easier with a Free Lung Cancer Screening
Saturday, November 8

Free Lung Cancer Screening

East Syracuse, NY - With November as Lung Cancer Awareness Month, Hematology/Oncology Associates of CNY (HOA) and CRA Medical Imaging (CRA) are offering free lung cancer screenings on Saturday, Nov. 8, 8 a.m. – 2 p.m. in two locations:

  • HOA, 5008 Brittonfield Parkway, East Syracuse, NY 13057
  • HOA, 5490 Cobbler Way, Camillus, NY 13031

Appointments are required by calling (315) 472-7504, extension 1301. Walk-ins cannot be accepted.

Infusion Services

Insist on expert infusion services in our comfortable,
state-of-the-art environment

Prostate Cancer

Safe and effective prostate cancer treatment
close to home, at HOA 

Cancer Q&A with HOA: Breast Cancer Awareness Month

When it comes to care during cancer treatment, patients like to know they’re in good hands and can trust the professionals serving them. That’s exactly what those at Hematology Oncology Associates of Central New York are all about.

Cancer Q&A with HOA: Radiopharmaceuticals As A New Treatment for Cancer

When it comes to care during cancer treatment, patients like to know they’re in good hands and can trust the professionals serving them. That’s exactly what those at Hematology Oncology Associates of Central New York are all about.

Rest & Recharge

Lymphoma, GO45434

The main goal of this trial is to study the frequency and severity of cytokine release syndrome (CRS) in participants with diffuse large B-cell lymphoma (DLBCL) who are using a combination of glofitamab + gemcitabine + oxaliplatin (Glofit-GemOx) followed by glofitamab-only treatment.

Multiple Myeloma, MajesTEC-7 64007957MMY3005

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).

Solid Tumor, S1937

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Pages